Anterior uveitis is one of the most common inflammatory diseases of the eye.

Many patients ask, “Will it come back?” and “Will the other eye be affected too?”
Last autumn, the results of a large study that answers these important questions were published1.
This is an excerpt from the American Academy of Ophthalmology’s official podcast of January 2, 2025.
Dr. Edmund Tsui of the University of California, Los Angeles (UCLA) hosted, with Dr. Rachael Niederer of New Zealand as guest, in a detailed discussion of the latest research on the risk of recurrence of anterior uveitis.
The discussion covered the point that “anterior uveitis recurs often.”
Recurrence Risk of Anterior Uveitis: What a Large Recent Study Found
Features of the Study
What stands out about this study is its scale and its careful follow-up methods:
Features of the Database
- Data from 2,092 patients (2,763 eyes) were analyzed
- Median follow-up of 8.9 years: long-term follow-up
- Observation data totaling about 20,000 eye-years
- Comprehensive follow-up that made use of New Zealand’s public health care system
Features of Diagnosis and Observation
- Detailed examination at the first visit (blood tests, imaging tests, and so on)
- A clear definition of recurrence (a flare-up after a symptom-free period of at least 3 months after the end of treatment)
- Regular follow-up by specialists
The Reality of Anterior UveitisRecurrence
Overall Recurrence Trends
The results show that recurrence of anterior uveitis is more common than expected:
Overall Trend
- About half of patients (50%) experience a recurrence
- Recurrence in the same eye: 45%
- Recurrence in the other eye: 27%
Changes Over Time
- Recurrences within 1 year of onset are relatively few
- Recurrences increase between 5 and 10 years
- This suggests the importance of long-term follow-up
Differences by Type of Disease
When caused by a virus
- Highest recurrence rate (especially cytomegalovirus and herpesviruses)
- Very little effect on the other eye (2%)
- Mostly affects only one eye
When the gene HLA-B27 is involved
- The other eye is affected relatively often (38%)
- Recurrence risk rises with age
- Attention must also be paid to links with systemic disease
Anterior Uveitis:Factors That Affect Recurrence

1. Effect of Age
- The older the patient, the more likely it is to recur
- The effect of age is particularly large when HLA-B27 is involved
- Older patients need more careful follow-up
2. Differences by Ethnicity
- The risk of recurrence is higher in people of Maori, Pacific Islander, and Asian ancestry
- Genetic and environmental factors may play a part
- Ease of access to medical care may also be involved
3. Other Factors
- No clear association with smoking was found
- However, detailed data on the amount smoked remain a task for future research
Recurrence of Anterior Uveitis:Effect on Vision

Long-Term Visual Prognosis
- Many patients keep generally good vision even after 10 years
- 15% have a moderate loss of vision
- The risk of vision loss is higher especially in older patients and in certain ethnic groups
Risk Factors for Vision Loss
- Early recurrence
- Onset at an older age
- Delay in appropriate treatment
Anterior Uveitis:The Importance of Prevention and Management

Preventive Treatment
When the cause is a virus
- HSV (herpes simplex virus): preventive use of valacyclovir
- CMV (cytomegalovirus): ganciclovir ointment or oral medication
- A medication plan tailored to each individual’s situation
The Importance of Regular Examinations
- A detailed eye examination at least once a year
- Early detection of complications by gonioscopy: secondary glaucoma may develop, among others
- Evaluation of the optic nerve by OCT
2. What Matters from the Patient’s Perspective
If HLA-B27 is positive
- Risk of recurrence in the same eye (40%)
- Risk of involvement of the other eye (more than 1/3)
- The importance of regular examinations
When the cause is a virus
- The risk of recurrence is about 50%
- Mostly affects only one eye
- The importance of preventive treatment
How to resume medication when a recurrence occurs, and the approach to tapering steroids gradually, are explained in the article on the overall picture of treatment.

Future Research Questions
Dr. Rachael Niederer’s research team points out the need for further research on the following points:
Points That Need Further Clarification
- The detailed causes of differences by ethnicity
- The influence of environmental factors
- Development of more effective prevention methods
Expected Future Prospects
- Establishing treatments suited to each individual patient
- More accurate prediction of recurrence risk
- Development of new preventive methods
Conclusion
This study has provided unprecedentedly detailed information on the recurrence of anterior uveitis.
It offers important insights for clinicians in planning treatment, and for patients in understanding and managing the disease.

The results show the importance of regular follow-up and appropriate preventive treatment.
If you are diagnosed with anterior uveitis, long-term management in close cooperation with your doctor is recommended.
References
- Brodie JT, Thotathil AZ, Jordan CA, Sims J, Niederer RL. Risk of Recurrence in Acute Anterior Uveitis. Ophthalmology. 2024 Nov;131(11):1281-1289. doi: 10.1016/j.ophtha.2024.06.003. Epub 2024 Jun 8. PMID: 38852922.
Note: This article is based on the content of the American Academy of Ophthalmology’s official podcast of January 2, 2025.
![Takeru Eye Clinic | Takatori Shopping Street, Sawara-ku, Fukuoka City [Nishijin Station / Fujisaki Station]](https://takeru-eye.com/wp-content/uploads/2022/10/takeru_logo_for-WP-header.png)

